BUSINESS● LOWAug 4 · Aug 4, 2026, 12:48 PM
Lisata Therapeutics moves forward with legal action following Kuva merger termination
Yahoo Finance
Lisata Therapeutics is pursuing legal action after the termination of its merger with Kuva. This indicates a significant legal development in the business world, stemming from a failed corporate merger.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESSnowMines, telecoms, factories… Will African industrialists succeed in doing without diesel?Jeune AfriqueBUSINESS21m agoAlvotech wins FDA nod for new manufacturing process for Humira biosimilarSeeking Alpha Tech